Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bayer Inc
Scientific Title
Phase 1b Multi-indication Study of Anetumab Ravtansine (BAY94-9343) in Patients With Mesothelin Expressing Advanced or Recurrent Malignancies